UA103544C2 - Кристалічна форма і цинкової солі розувастатину - Google Patents
Кристалічна форма і цинкової солі розувастатинуInfo
- Publication number
- UA103544C2 UA103544C2 UAA201201836A UAA201201836A UA103544C2 UA 103544 C2 UA103544 C2 UA 103544C2 UA A201201836 A UAA201201836 A UA A201201836A UA A201201836 A UAA201201836 A UA A201201836A UA 103544 C2 UA103544 C2 UA 103544C2
- Authority
- UA
- Ukraine
- Prior art keywords
- crystalline form
- zinc salt
- rosuvastatin zinc
- rosuvastatin
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Даний винахід стосується кристалічної форми І солі розувастатину цинку (2:1), способу її одержання та її застосування як фармацевтично активного інгредієнта для лікування захворювань, пов'язаних з метаболізмом ліпідів, що включають гіперліпопротеїнемію, гіперхолестеринемію, дисліпідемію і атеросклероз.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/HU2009/000064 WO2011010174A1 (en) | 2009-07-24 | 2009-07-24 | Crystalline form i rosuvastatin zinc salt |
Publications (1)
Publication Number | Publication Date |
---|---|
UA103544C2 true UA103544C2 (uk) | 2013-10-25 |
Family
ID=41258771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201201836A UA103544C2 (uk) | 2009-07-24 | 2009-07-24 | Кристалічна форма і цинкової солі розувастатину |
Country Status (11)
Country | Link |
---|---|
US (1) | US9023838B2 (uk) |
EP (1) | EP2483248B1 (uk) |
JP (1) | JP5702778B2 (uk) |
CN (1) | CN102548971B (uk) |
AU (1) | AU2009350099B2 (uk) |
EA (1) | EA020944B1 (uk) |
ES (1) | ES2598162T3 (uk) |
HU (1) | HUE029858T2 (uk) |
IL (1) | IL217898A0 (uk) |
UA (1) | UA103544C2 (uk) |
WO (1) | WO2011010174A1 (uk) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230737B1 (hu) * | 2010-11-16 | 2018-01-29 | EGIS Gyógyszergyár Nyrt | Eljárás rosuvastatin só előállítására |
HU231036B1 (hu) * | 2013-09-30 | 2019-12-30 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2576196A1 (en) * | 2004-08-06 | 2006-02-16 | Transform Pharmaceuticals, Inc. | Novel statin pharmaceutical compositions and related methods of treatment |
HU227696B1 (en) * | 2006-04-13 | 2011-12-28 | Egyt Gyogyszervegyeszeti Gyar | Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it |
WO2008015563A2 (en) * | 2006-08-04 | 2008-02-07 | Glenmark Pharmaceuticals Limited | Salts of rosuvastatin and processes for their preparation |
HU230981B1 (hu) * | 2007-10-12 | 2019-08-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin só előállítására |
HU230637B1 (hu) * | 2007-10-12 | 2017-05-29 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin intermedierek előállítására |
CN102317267A (zh) * | 2009-01-15 | 2012-01-11 | 埃吉斯药物股份公开有限公司 | 制备罗苏伐他汀盐的方法 |
-
2009
- 2009-07-24 WO PCT/HU2009/000064 patent/WO2011010174A1/en active Application Filing
- 2009-07-24 HU HUE09785765A patent/HUE029858T2/en unknown
- 2009-07-24 CN CN200980160962.0A patent/CN102548971B/zh not_active Expired - Fee Related
- 2009-07-24 JP JP2012521105A patent/JP5702778B2/ja not_active Expired - Fee Related
- 2009-07-24 AU AU2009350099A patent/AU2009350099B2/en active Active
- 2009-07-24 US US13/383,490 patent/US9023838B2/en not_active Expired - Fee Related
- 2009-07-24 ES ES09785765.0T patent/ES2598162T3/es active Active
- 2009-07-24 UA UAA201201836A patent/UA103544C2/uk unknown
- 2009-07-24 EA EA201290051A patent/EA020944B1/ru not_active IP Right Cessation
- 2009-07-24 EP EP09785765.0A patent/EP2483248B1/en active Active
-
2012
- 2012-02-02 IL IL217898A patent/IL217898A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201290051A1 (ru) | 2012-09-28 |
WO2011010174A1 (en) | 2011-01-27 |
IL217898A0 (en) | 2012-03-29 |
US20120178729A1 (en) | 2012-07-12 |
HUE029858T2 (en) | 2017-04-28 |
AU2009350099A1 (en) | 2012-03-08 |
ES2598162T3 (es) | 2017-01-25 |
EA020944B1 (ru) | 2015-02-27 |
JP5702778B2 (ja) | 2015-04-15 |
JP2013500250A (ja) | 2013-01-07 |
EP2483248A1 (en) | 2012-08-08 |
EP2483248B1 (en) | 2016-07-20 |
US9023838B2 (en) | 2015-05-05 |
CN102548971A (zh) | 2012-07-04 |
AU2009350099B2 (en) | 2015-10-29 |
CN102548971B (zh) | 2015-09-16 |
WO2011010174A8 (en) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY177742A (en) | Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine | |
EA202091303A2 (ru) | Композиция ингибитора jak для местного применения | |
WO2010132999A8 (en) | Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics | |
MX2012015292A (es) | Pirazolo[1, 5]pirimidinas en la forma de agentes antivirales. | |
MX2015011955A (es) | Lipidos y composiciones de lipidos para el suministro de agentes activos. | |
GEP201706620B (en) | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS | |
AU2012258977A8 (en) | Inhibitors of LRRK2 kinase activity | |
MX338088B (es) | Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf). | |
MY164864A (en) | Indenone derivative and pharmaceutical composition comprising same | |
MX2021010046A (es) | Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas. | |
MY155938A (en) | Oral pharmaceutical composition | |
MX2012013478A (es) | Composicion para evitar perdida del cabello o estimular crecimiento del cabello. | |
UA112423C2 (uk) | Спосіб одержання (варіанти) кристалічних форм розувастатину тба | |
IN2013DN02555A (uk) | ||
MX343165B (es) | Agonistas del receptor 5-ht4 para el tratamiento de demencia. | |
UA103544C2 (uk) | Кристалічна форма і цинкової солі розувастатину | |
MY182553A (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
NZ611072A (en) | Method for preparing rosuvastatin salts | |
MX353991B (es) | Agonista del receptor de 5-ht4 como agente procinetico. | |
HU1000616D0 (en) | Crystalline pharmaceutically active ingredient | |
MX2010011006A (es) | Nueva sal de un derivado de pirimidina. | |
NZ609804A (en) | Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid | |
WO2012072791A3 (en) | 2-(1-phenyl-4,5,6,7-tetrahydro-1h-indazol-4-yl)ethylamine derivatives useful as sigma receptor inhibitors | |
WO2010128346A3 (en) | Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability | |
EP2407454A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR OPTICAL NERVE DISORDERS COMPRISING A DERIVATIVE OR SALT OF 4,6-DICHLORO-1H-INDOLE-2-CARBOXYLIC ACID AS ACTIVE INGREDIENT |